Nebraska Oncology Society

Event

Annual Midwest Regional Mid Year Review 2024

presented by Nebraska Oncology Society

2 others would like to attend.

Register Now

Notification icon Saturday, June 22, 2024 7:30 AM - 2 PM America/Chicago

Location Icon 12520 Westport Pkwy, La Vista, Nebraska

Event info

OVERVIEW

Please join the Nebraska Oncology Society virtually on Saturday, June 22, 2024 for the Annual Midwest Regional Mid Year Review from 7:30am to 2:00pm CDT. In our 25th year of hosting this review for the oncology community, the Nebraska Oncology Society  is looking forward to offering you this comprehensive review of the latest updates and therapeutic advances in the treatment of malignancies. Our event will take place at the Embassy Suites La Vista Conference Center, 12520 Westport Parkway, La Vista, Nebraska.

Join our event and be a part of a spectacular educational review!

ACCREDITATION

Category 1​

Creighton University Health Sciences Continuing Education designates this live activity for a maximum of 5.0 AMA PRA Category 1 Credit(s) TM.  Physicians should claim only credit commensurate with the extent of their participation in the activity.​

Nurse CE​

Creighton University Health Sciences Continuing Education designates this activity for 5.0 contact hours for nurses.  Nurses should claim only credit commensurate with the extent of their participation in the activity.​

Accreditation Statement​

In support of improving patient care, this activity has been planned and implemented by Creighton University Health Sciences Continuing Education and Nebraska Oncology Society (NOS).  Creighton University Health Sciences Continuing Education (HSCE) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

For more information please visit the official event page.

2 others would like to attend.

Register Now


Comments 0
Login to view comments. Click here to Login